My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 344

    1.

    Peptide inhibitors of dengue virus and West Nile virus infectivity.

    Hrobowski YM, Garry RF, Michael SF.

    Virol J. 2005 Jun 1;2:49.PMID: 15927084 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

    Chu JJ, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng ML.

    J Gen Virol. 2005 Feb;86(Pt 2):405-12.PMID: 15659760 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Identification of novel target sites and an inhibitor of the dengue virus E protein.

    Yennamalli R, Subbarao N, Kampmann T, McGeary RP, Young PR, Kobe B.

    J Comput Aided Mol Des. 2009 Jun;23(6):333-41. Epub 2009 Feb 25.PMID: 19241120 [PubMed - indexed for MEDLINE]Related articles

    4.

    In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.

    Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR.

    Antiviral Res. 2009 Dec;84(3):234-41. Epub 2009 Sep 23.PMID: 19781577 [PubMed - indexed for MEDLINE]Related articles

    5.

    An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein.

    Piñón JD, Kelly SM, Price NC, Flanagan JU, Brighty DW.

    J Virol. 2003 Mar;77(5):3281-90.PMID: 12584351 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.

    Lamb D, Schüttelkopf AW, van Aalten DM, Brighty DW.

    Retrovirology. 2008 Aug 4;5:70.PMID: 18680566 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Antiviral peptides targeting the west nile virus envelope protein.

    Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E.

    J Virol. 2007 Feb;81(4):2047-55. Epub 2006 Dec 6.PMID: 17151121 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

    Kanai R, Kar K, Anthony K, Gould LH, Ledizet M, Fikrig E, Marasco WA, Koski RA, Modis Y.

    J Virol. 2006 Nov;80(22):11000-8. Epub 2006 Aug 30.PMID: 16943291 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.

    Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.

    Virus Res. 2006 Sep;120(1-2):146-55. Epub 2006 Apr 17.PMID: 16616792 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection.

    Hobson-Peters J, Toye P, Sánchez MD, Bossart KN, Wang LF, Clark DC, Cheah WY, Hall RA.

    J Gen Virol. 2008 Dec;89(Pt 12):3063-72.PMID: 19008394 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.

    Porotto M, Carta P, Deng Y, Kellogg GE, Whitt M, Lu M, Mungall BA, Moscona A.

    J Virol. 2007 Oct;81(19):10567-74. Epub 2007 Jul 25.PMID: 17652384 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease.

    Nall TA, Chappell KJ, Stoermer MJ, Fang NX, Tyndall JD, Young PR, Fairlie DP.

    J Biol Chem. 2004 Nov 19;279(47):48535-42. Epub 2004 Aug 18.PMID: 15322074 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.

    Netter RC, Amberg SM, Balliet JW, Biscone MJ, Vermeulen A, Earp LJ, White JM, Bates P.

    J Virol. 2004 Dec;78(24):13430-9.PMID: 15564453 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.

    Goncalvez AP, Purcell RH, Lai CJ.

    J Virol. 2004 Dec;78(23):12919-28.PMID: 15542644 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.

    Chu JH, Chiang CC, Ng ML.

    J Immunol. 2007 Mar 1;178(5):2699-705.PMID: 17312111 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo.

    Whitby K, Pierson TC, Geiss B, Lane K, Engle M, Zhou Y, Doms RW, Diamond MS.

    J Virol. 2005 Jul;79(14):8698-706.PMID: 15994763 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Crystal structure of the West Nile virus envelope glycoprotein.

    Nybakken GE, Nelson CA, Chen BR, Diamond MS, Fremont DH.

    J Virol. 2006 Dec;80(23):11467-74. Epub 2006 Sep 20.PMID: 16987985 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.

    Yao Q, Compans RW.

    Virology. 1996 Sep 1;223(1):103-12.PMID: 8806544 [PubMed - indexed for MEDLINE]Related articles

    19.

    Nonhelical leash and alpha-helical structures determine the potency of a peptide antagonist of human T-cell leukemia virus entry.

    Mirsaliotis A, Lamb D, Brighty DW.

    J Virol. 2008 May;82(10):4965-73. Epub 2008 Feb 27.PMID: 18305034 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Constancy and diversity in the flavivirus fusion peptide.

    Seligman SJ.

    Virol J. 2008 Feb 14;5:27.PMID: 18275613 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk